RHY 1.67% 6.1¢ rhythm biosciences limited

Good point about companies protecting their own best interests...

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    Good point about companies protecting their own best interests @goedy
    This could well be the barrier which Rhythm are trying to break through with any negotiations they have underway. A deal with a major company already selling CRC screening tests would be brilliant (e.g. Exact, Sonic) however these companies have already cornered the market with their stool tests. Wouldn't they be foolish not to grab rights to Rhythm's technology though? To protect their monopoly of the sector if nothing else!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.